CN106387900A - Composition for regulating blood lipid, blood pressure and blood sugar, as well as application thereof - Google Patents
Composition for regulating blood lipid, blood pressure and blood sugar, as well as application thereof Download PDFInfo
- Publication number
- CN106387900A CN106387900A CN201610818255.8A CN201610818255A CN106387900A CN 106387900 A CN106387900 A CN 106387900A CN 201610818255 A CN201610818255 A CN 201610818255A CN 106387900 A CN106387900 A CN 106387900A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood
- oil
- blood pressure
- compositionss
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 111
- 239000008280 blood Substances 0.000 title claims abstract description 110
- 230000036772 blood pressure Effects 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 title abstract description 28
- 150000002632 lipids Chemical class 0.000 title abstract description 10
- 230000001105 regulatory effect Effects 0.000 title abstract 4
- 239000003921 oil Substances 0.000 claims abstract description 50
- 235000019198 oils Nutrition 0.000 claims abstract description 50
- 239000000835 fiber Substances 0.000 claims abstract description 45
- 239000006041 probiotic Substances 0.000 claims abstract description 43
- 230000000529 probiotic effect Effects 0.000 claims abstract description 43
- 235000018291 probiotics Nutrition 0.000 claims abstract description 43
- 244000179886 Moringa oleifera Species 0.000 claims abstract description 22
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 22
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 22
- 235000008434 ginseng Nutrition 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 235000021323 fish oil Nutrition 0.000 claims abstract description 15
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims abstract description 14
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000013305 food Nutrition 0.000 claims abstract description 11
- 229940106134 krill oil Drugs 0.000 claims abstract description 8
- 235000012055 fruits and vegetables Nutrition 0.000 claims abstract description 3
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 3
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 3
- 241000894006 Bacteria Species 0.000 claims description 45
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 34
- 239000008103 glucose Substances 0.000 claims description 34
- 210000000582 semen Anatomy 0.000 claims description 24
- 235000011201 Ginkgo Nutrition 0.000 claims description 21
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 21
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 21
- 230000001603 reducing effect Effects 0.000 claims description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 239000010495 camellia oil Substances 0.000 claims description 13
- 239000001963 growth medium Substances 0.000 claims description 8
- -1 pollen Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 6
- 239000011651 chromium Substances 0.000 claims description 6
- 229910052804 chromium Inorganic materials 0.000 claims description 6
- 229940046374 chromium picolinate Drugs 0.000 claims description 5
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 4
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 238000000855 fermentation Methods 0.000 claims description 4
- 230000004151 fermentation Effects 0.000 claims description 4
- 239000001630 malic acid Substances 0.000 claims description 4
- 235000011090 malic acid Nutrition 0.000 claims description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 3
- 239000003472 antidiabetic agent Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 2
- 241000186012 Bifidobacterium breve Species 0.000 claims description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 2
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 2
- 241000186866 Lactobacillus thermophilus Species 0.000 claims description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 2
- 244000099147 Ananas comosus Species 0.000 claims 1
- 235000007119 Ananas comosus Nutrition 0.000 claims 1
- 244000000626 Daucus carota Species 0.000 claims 1
- 235000002767 Daucus carota Nutrition 0.000 claims 1
- 240000008620 Fagopyrum esculentum Species 0.000 claims 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims 1
- 244000068988 Glycine max Species 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 10
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- 244000247812 Amorphophallus rivieri Species 0.000 abstract 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 abstract 1
- 240000001548 Camellia japonica Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000195493 Cryptophyta Species 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 244000017020 Ipomoea batatas Species 0.000 abstract 1
- 235000002678 Ipomoea batatas Nutrition 0.000 abstract 1
- 229920002752 Konjac Polymers 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000015197 apple juice Nutrition 0.000 abstract 1
- 235000018597 common camellia Nutrition 0.000 abstract 1
- 235000010485 konjac Nutrition 0.000 abstract 1
- 239000000252 konjac Substances 0.000 abstract 1
- 235000021388 linseed oil Nutrition 0.000 abstract 1
- 239000000944 linseed oil Substances 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 description 42
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 31
- 239000008187 granular material Substances 0.000 description 22
- 241000208340 Araliaceae Species 0.000 description 19
- 241000218628 Ginkgo Species 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 13
- 206010020772 Hypertension Diseases 0.000 description 11
- 230000033228 biological regulation Effects 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000031226 Hyperlipidaemia Diseases 0.000 description 9
- 210000004204 blood vessel Anatomy 0.000 description 9
- 230000009286 beneficial effect Effects 0.000 description 8
- 235000012000 cholesterol Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000239366 Euphausiacea Species 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000002218 hypoglycaemic effect Effects 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 239000012467 final product Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 201000001421 hyperglycemia Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000004531 blood pressure lowering effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 235000020256 human milk Nutrition 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 2
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011443 conventional therapy Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000004026 insulin derivative Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000005492 Myriopteron extensum Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 240000003243 Thuja occidentalis Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- UNWAHVGSROASNT-HXNJGWPRSA-N amarolide Chemical compound C[C@H]1C(=O)[C@@H](O)[C@@H]2[C@@]3(C)C(=O)[C@@H](O)C[C@@H](C)[C@@H]3C[C@@H]3[C@@]2(C)[C@H]1CC(=O)O3 UNWAHVGSROASNT-HXNJGWPRSA-N 0.000 description 1
- UNWAHVGSROASNT-UHFFFAOYSA-N amarolide Natural products CC1C(=O)C(O)C2C3(C)C(=O)C(O)CC(C)C3CC3C2(C)C1CC(=O)O3 UNWAHVGSROASNT-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical group 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940127017 oral antidiabetic Drugs 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- HSTCACQRSLZQHZ-UHFFFAOYSA-N shinjulactone H Natural products CC1CC(O)C(=O)C2(C)C1CC3OC(=O)CC4C(C)C(O)C(=O)C2C34C HSTCACQRSLZQHZ-UHFFFAOYSA-N 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229930193551 sterin Natural products 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a composition for regulating blood lipid, blood pressure and blood sugar, and belongs to the field of medicines or foods. The composition for regulating the blood lipid, the blood pressure and the blood sugar comprises the following raw materials in parts by weight: 1800-2200 parts probiotic enzymes, 5-30 parts of L-arabinose, 2-10 parts of moringa, 2-10 parts of samara fruit oil, 5-15 parts of gingko leaves, 3-10 parts of krill oil, 2-10 parts of deep-sea fish oil, 2-10 parts of DHA algae oil, 2-10 parts of linseed oil, 2-10 parts of camellia seed oil, 2-10 parts of hawthorn fruits, 2-10 parts of lotus leaves, 3-10 parts of cassia seeds, 2-10 parts of fruit and vegetable fiber, 2-10 parts of grain fiber, 1-5 parts of konjac, 1-5 parts of purple sweet potatoes, 1-5 parts of Chinese wolfberry fruits, 1-5 parts of poria cocos, 1-5 parts of ginsengs and 2-10 parts of apple juice. The composition is rich in multiple nutrients and active ingredients, and is capable of very well regulating the blood lipid, blood pressure and blood sugar levels of the body. Moreover, the invention also relates to application of the composition.
Description
Technical field
The present invention relates to medicine or field of food, and particularly to a kind of adjust blood fat, the compositionss of blood pressure and blood glucose and
Its application.
Background technology
Development with social economy and living-pattern preservation, hypertension, hyperglycemia, hyperlipidemia (inclusion hypercholesterolemia)
Deng sickness rate raise year by year.Hypertension, hyperglycemia, hyperlipidemia are that diabetes, coronary heart disease, the brain contour lethal height of soldier are disabled disease
Pathologic basis, especially when three coexists, it is bigger relatively to there is single disease in its harm.Hyperlipidemia refer to blood cholesterol or/
Raise with triglyceride concentration, blood vessel embolism can be caused, be to lead to atherosclerotic key factor；Hypertension can cause
Cerebral hemorrhage and rupture of blood vessel in brain, are the key factors leading to cardiovascular disease；Hyperglycemia can cause diabetes, or even causes multiple
Complication.
At present, the treatment of the diseases such as hypertension, hyperlipidemia, hyperglycemia is taken with the plan of various disease disease drug combination
Slightly, increased medicine and use kind and the financial burden of patient.Meanwhile, using western medicine, often suffer from some infringements
The side effect of person's body function.Some blood fat reducing, blood pressure lowering or hypoglycemic health food are existed on market, it adjusts body blood
The function of fat, blood pressure and blood glucose is all weaker, inconspicuous to the action effect of disease.
Content of the invention
It is an object of the invention to provide a kind of compositionss adjusting blood fat, blood pressure and blood glucose, this compositions has regulation
The function of the blood fat (inclusion cholesterol), blood pressure and blood sugar level of body, treatment hyperlipidemia (inclusion hypercholesterolemia), hypertension and
The effect of hyperglycemia is obvious.
Another object of the present invention is to provide a kind of adjust blood fat, blood pressure and blood glucose compositionss preparation blood fat reducing,
Application in blood pressure lowering or hypoglycemic drug.
Another object of the present invention is to provide a kind of adjust blood fat, blood pressure and blood glucose compositionss preparation blood fat reducing,
Application in blood pressure lowering or blood sugar reducing food.
In order to realize the above-mentioned purpose of the present invention, spy employs the following technical solutions：
A kind of compositionss adjusting blood fat, blood pressure and blood glucose, in parts by weight, the raw material of said composition includes：Benefit
Raw bacterium ferment 1800-2200 part, L-arabinose 5-30 part, Moringa 2-10 part, samara oil 2-10 part, Folium Ginkgo 5-15 part, phosphorus
Shrimp sauce 3-10 part, bathypelagic fish oil 2-10 part, DHA algal oil 2-10 part, Semen Lini oil 2-10 part, Camellia oil 2-10 part, Fructus Crataegi 2-
10 parts, Folium Nelumbinis 2-10 part, Semen Cassiae 3-10 part, fruit-vegetable fibre 2-10 part, Five-grain fiber 2-10 part, Rhizoma amorphophalli 1-5 part, Rhizoma Steudnerae Henryanae 1-5
Part, Fructus Lycii 1-5 part, Poria 1-5 part, Radix Ginseng 1-5 part and Sucus Mali pumilae 2-10 part.
In addition, the compositionss of above-mentioned regulation blood fat, blood pressure and blood glucose are in preparation blood fat reducing, blood pressure lowering or blood sugar lowering medicine
Application.
In addition, the compositionss of above-mentioned regulation blood fat, blood pressure and blood glucose are in preparation blood fat reducing, blood pressure lowering or blood sugar reducing food
Application.
Compared with prior art, beneficial effects of the present invention are：
This compositionss composition based on probiotic bacteria ferment, probiotic bacteria ferment be by probiotic bacteria on probiotic bacteria culture medium
The product of cultivation and fermentation.Probiotic bacteria is the class active microorganism beneficial to host, is to be colonized in human body intestinal canal, system genitale
In system, definite health efficacy can be produced thus improving host's microecological balance, the active beneficial microorganism of performance beneficial effect
General name.Probiotic bacteria includes bacillus bifiduss, lactobacilluss, yeast etc., is the requisite key element of health, can synthesize each
Plant vitamin, participate in food digestion, promote intestinal peristalsis promoting, prevent pathogenic flora growth etc..Probiotic bacteria ferment is a kind of new benefit
Raw bacterium product, probiotic bacteria growth metabolism on probiotic bacteria culture medium produces various active material.Scientific investigations showed that, probiotic bacteria ferment
Element can promote the metabolism of human body, decompose the cholesterol in blood and high blood lipoprotein, can effectively lower serum cholesterol
Level；Decompose the fat of Ink vessel transfusing and deposition in blood vessel wall, make blood circulation, blood vessel elasticity reparation, lower blood pressure and blood fat water
Flat；Promote cell regeneration, make body produce more insulins, reducing blood glucose level.
Meanwhile, L-arabinose has blocking effect to the conversion of sucrose, effect pole in terms of fat-reducing, control diabetes
Good.Abundant unsaturated fatty acid is contained in Moringa, krill oil, bathypelagic fish oil, DHA algal oil, Semen Lini oil and Camellia oil, can
Effectively reduce the content of Blood Cholesterol and triglyceride, reduce blood pressure, reduce lipids contents, prevent angiemphraxises and have
Related disorders.In order to adjust physical function, promote lowering blood pressure and blood fat and hypoglycemic effect further, be also added with Fructus Crataegi, lotus
The becoming of these traditional Chinese medicines of leaf, Semen Cassiae, fruit-vegetable fibre, Five-grain fiber, Rhizoma amorphophalli, Rhizoma Steudnerae Henryanae, Fructus Lycii, Poria and Radix Ginseng or food
Point.
In the compositionss that the present invention provides, each material composition is natural product, it is to avoid synthetic material is brought
Side effect.When in compositionss, each composition cooperates, each composition has synergism, is capable of effect of enhancing composition.Combination
Thing has blood fat reducing, blood pressure lowering and hypoglycemic effect simultaneously, evident in efficacy.And the present invention is not likely to produce drug resistance, nontoxic
Side effect and untoward reaction.
Specific embodiment
Purpose, technical scheme and advantage for making the embodiment of the present invention are clearer, below will be in the embodiment of the present invention
Technical scheme be clearly and completely described.In embodiment, unreceipted actual conditions person, builds according to normal condition or manufacturer
The condition of view is carried out.Agents useful for same or the unreceipted production firm person of instrument, being can be by the commercially available conventional product bought and obtain
Product.
Below the compositionss adjusting blood fat, blood pressure and blood glucose of the embodiment of the present invention are specifically described.
A kind of compositionss adjusting blood fat, blood pressure and blood glucose provided in an embodiment of the present invention, in parts by weight, this group
The raw material of compound includes：Probiotic bacteria ferment 1800-2200 part, L-arabinose 5-30 part, Moringa 2-10 part, samara oil 2-10
Part, Folium Ginkgo 5-15 part, krill oil 3-10 part, bathypelagic fish oil 2-10 part, DHA algal oil 2-10 part, Semen Lini oil 2-10 part, Flos Camelliae Japonicae
Seed oil 2-10 part, Fructus Crataegi 2-10 part, Folium Nelumbinis 2-10 part, Semen Cassiae 3-10 part, fruit-vegetable fibre 2-10 part, Five-grain fiber 2-10 part,
Rhizoma amorphophalli 1-5 part, Rhizoma Steudnerae Henryanae 1-5 part, Fructus Lycii 1-5 part, Poria 1-5 part, Radix Ginseng 1-5 part and Sucus Mali pumilae 2-10 part.
Probiotic bacteria ferment is by the product of probiotic bacteria cultivation and fermentation on probiotic bacteria culture medium.Probiotic bacteria is a class pair
The beneficial active microorganism of host, is to be colonized in human body intestinal canal, in reproductive system, producing definite health efficacy thus improving place
Main microecological balance, the active beneficial microorganism general name of performance beneficial effect.Probiotic bacteria include bacillus bifiduss, lactobacilluss,
Yeast etc., is the requisite key element of health, can synthesize various vitamin, participates in food digestion, promotes intestinal compacted
Dynamic, prevent pathogenic flora growth etc..Probiotic bacteria ferment is a kind of new probiotic bacterium product, probiotic bacteria generation in probiotic bacteria culture medium
Thank to generation various active material.Scientific investigations showed that, probiotic bacteria ferment can promote the metabolism of human body, decompose in blood
Cholesterol and high blood lipoprotein, can effectively lower serum cholesterol level；Decompose the fat of Ink vessel transfusing and deposition in blood vessel wall, make
Blood circulation, blood vessel elasticity reparation, lower blood pressure and blood lipid level；Promote cell regeneration, make body produce more insulins,
Reducing blood glucose level.
Moringa, also known as drumstick tree, is described as " Tree of Life ", and it contains abundant nutrient, is widely used in improvement
Various diseases, and achieve noticeable achievement.
Folium Ginkgo, containing the multiple components beneficial to health such as natural activity flavone and amarolide, has dissolving gallbladder
Sterin, the effect of expansion of blood vessels, to improve disordered brain function, arteriosclerosis, hypertension, dizziness, tinnitus, headache, senile dementia,
Hypomnesis etc. has positive effect.Modern study proves, Folium Ginkgo can obviously reduce serum cholesterol, triglyceride and low close
The content of degree blood lipoprotein, reduces internal depot lipid.For diseases of cardiovascular and cerebrovascular systems such as hyperlipidemia, hypertension and coronary heart disease
Fat-reducing of the complementary preventing and treating of patient and obese type crowd etc. has functions that good.
Krill oil, containing multiple unsaturated fatty acids such as ω -3 essential fatty acid (including EPA and DHA), U.S. clinical is demonstrate,proved
Real, krill oil has superpower blood fat reducing, blood sugar lowering, antihypertensive function, can pass through blood brain barrier nutrition and activation brain cell
And nerve, play prevention and treatment cerebrovascular disease；Meanwhile, coronary atherosclerosiies, coronary heart disease are prevented and treated, prevention is sent out
The cardiovascular disease such as raw heart infarction, support, bridging and secondary recurrence.
Samara oil, its protein is made up of 17 kinds of aminoacid, and also multiple aminoacid needed by human.α-Asia in Myriopteron extensum (Wight) K. Schum
The ratio of the content of fiber crops sour and sub- spunyarn acid is 1:7, the closely ratio of breast milk, its nutritional labeling is equally very rich also like breast milk
Rich, equilibrium, comprehensively, easily absorbed by the body, it is referred to as " natural breast milk ".
Bathypelagic fish oil, DHA algal oil, Semen Lini oil and Camellia oil, containing abundant unsaturated fatty acid (include DHA and
EPA), can effectively reduce the content of Blood Cholesterol and triglyceride, reduce blood pressure, reduce lipids contents, prevent blood vessel
Block and have related disorders.
Fructus Crataegi, main component is flavonoid and organic acid compound, has regulation blood fat, adjusts carbohydrate metabolism, blood pressure lowering etc.
Effect.Fructus Crataegi contains substantial amounts of vitamin C and trace element, can expansion of blood vessels, reduce blood pressure, reduce blood glucose, can improve
With promote Cholesterol Excretion and reduction blood fat, the generation of prevention hyperlipidemia, Fructus Crataegi can be whetted the appetite facilitating digestion, contained by Fructus Crataegi
Digestive Enzyme also can promote the digestion of fat.
Folium Nelumbinis, containing multiple alkaloid such as nuciferine, miltanthin and nuciferine and vitamin C, polysaccharide.Recent studiess are demonstrate,proved
Real, Folium Nelumbinis play the role of good blood fat reducing, cholesterol reducing and fat-reducing.
Semen Cassiae, has the function of liver heat removing and eyesight improving, relieving constipation, cure mainly hypertension, headache, dizziness, acute conjunctivitiss, cornea burst
The diseases such as infectionss, glaucoma, carbuncle furuncle sore.
Fruit-vegetable fibre and Five-grain fiber, rich in dietary fiber, can effectively prevent and treat such as constipation, obesity, arteriosclerosis,
The diseases such as cardiovascular and cerebrovascular disease, diabetes, dietary fiber can slow down digestion rate and rapid drainage cholesterol, can allow in blood
Blood glucose and cholesterol control on optimal level, also assist in diabeticss reduce internal insulin and three acid sweet
The content of oils and fatss.
Rhizoma amorphophalli, containing glucomannan, dietary fiber etc., has the multiple efficacies such as lipid-loweringing, blood sugar lowering, anti-cancer, relieving constipation.
Rhizoma Steudnerae Henryanae, containing abundant nutritional labeling, be eaten for a long time with blood pressure lowering, enrich blood, QI invigorating, lung moistening, skin care the effect of, energy
The diseases such as enough effective prevention of arterial hardening.
Fructus Lycii, Poria, Radix Ginseng, are traditional Chinese medicine, have the effects such as blood sugar lowering, anti-fatty liver, atherosclerosiss.
Sucus Mali pumilae, containing soluble fiber, can prevent accumulation of cholesterol, reduce LDL value and cholesterol level.
Further, in present pre-ferred embodiments, in parts by weight, above-mentioned probiotic bacteria ferment is 2000 parts,
L-arabinose is 10-20 part, and Moringa is 3-5 part, is samara oil 3-5 part, and Folium Ginkgo is 10-12 part, and krill oil is 5-7 part,
Bathypelagic fish oil is 3-5 part, and DHA algal oil is 3-5 part, and Semen Lini oil is 3-5 part, and Camellia oil is 3-5 part, and Fructus Crataegi is 3-5 part, lotus
Leaf is 2-3 part, and Semen Cassiae is 5-8 part, and fruit-vegetable fibre is 3-5 part, and Five-grain fiber is 3-5 part, and Rhizoma amorphophalli is 2-3 part, and Rhizoma Steudnerae Henryanae is 2-3
Part, Fructus Lycii is 1-2 part, and Poria is 1-2 part, and Radix Ginseng is 1-2 part, and Sucus Mali pumilae is 3-5 part.By the compositionss of this proportions,
Its blood fat reducing, blood pressure lowering and hypoglycemic effect are higher, and the proportioning effect of functional components is more excellent.
Further, in present pre-ferred embodiments, compositionss also include sodium carboxymethyl cellulose, citric acid, Fructus Mali pumilae
Sour, organic trivalent chromium and chromium picolinate.Citric acid and malic acid are natural organic acid, the effects such as except having blood pressure lowering
Outward, local flavor and the mouthfeel of compositionss can also be effectively improved, be more easy to be accepted by consumer.Organic trivalent chromium is glucose tolerance
The important activity composition of the factor, to adjusting carbohydrate metabolism, maintenance, normal tolerance plays an important role in vivo, and it can affect body
Lipid metabolism, reduces the content of blood cholesterol and triglyceride.Pyridine carboxylic acid is to produce in people and mammalian liver, kidney
Amino acid metabolites, it is closely integrated into chromium picolinate with organic trivalent chromium, can be absorbed well by human body.Carboxylic first
Base sodium cellulosate is good stabilizer, thickening agent, bonding agent and film former, all has and widely should in food and medicine industry
With, have excellent freeze, melt stability, and the local flavor of product can be improved, extend storage time.
Further, in present pre-ferred embodiments, probiotic bacteria ferment mainly by probiotic bacteria on probiotic bacteria culture medium
Cultivation and fermentation is obtained.In parts by weight, probiotic bacteria includes：Bifidobacterium adolescentiss 20-100 part, bacillus acidophilus 20-100
Part, lactobacillus thermophiluss 20-100 part, bifidobacterium breve 20-100 part, bifidobacterium longum 20-100 part and Lactobacillus plantarum 20-
100 parts.Wherein, the main component of probiotic bacteria culture medium be mushroom polysaccharide, algal polysaccharides, Plant Powder, pollen, water fruits and vegetables with
And grain rice.
Multiple active skull cap components are contained using the probiotic bacteria ferment that above-mentioned raw materials are obtained, its lowering blood pressure and blood fat and fall
Effect of blood glucose is higher.
Further, in present pre-ferred embodiments, the raw material of above-mentioned composition also includes pharmaceutically acceptable auxiliary
Material, such as starch, magnesium stearate, oligosaccharide etc., the compositionss preparing can for oral liquid, tablet, capsule, powder,
Granule, solid granules etc., may also be beverage, gel candy, wine etc..
The compositionss that the present invention provides have good lowering blood pressure and blood fat and hypoglycemic effect, can be used in system
The application made preparation for dropping in blood fat, blood pressure lowering or hypoglycemic drug.The medicine preparing can be oral liquid, tablet, capsule, powder
Agent, granule or solid granules etc..
The compositionss that the present invention provides have good lowering blood pressure and blood fat and hypoglycemic effect, can be used in system
The application made preparation for dropping in blood fat, blood pressure lowering or blood sugar reducing food.The food preparing has good health-care effect, can be drink
Product, gel candy or wine etc..
With reference to embodiments the feature and performance of the present invention is described in further detail.
Embodiment 1
The compositionss of a kind of regulation blood fat, blood pressure and blood glucose that the present embodiment provides, in parts by weight, said composition
Raw material include：2000 parts of probiotic bacteria ferment, 15 parts of L-arabinose, 4 parts of Moringa, 4 parts of samara oil, 11 parts of Folium Ginkgo, krill
6 parts of oil, 4 parts of bathypelagic fish oil, 4 parts of DHA algal oil, 4 parts of Semen Lini oil, 4 parts of Camellia oil, 4 parts of Fructus Crataegi, 2 parts of Folium Nelumbinis, Semen Cassiae 7
Part, 4 parts of fruit-vegetable fibre, 4 parts of Five-grain fiber, 3 parts of Rhizoma amorphophalli, 2 parts of Rhizoma Steudnerae Henryanae, 2 parts of Fructus Lycii, 1 part of Poria, 2 parts of Radix Ginseng and Sucus Mali pumilae 4
Part.
Said composition is made granule, it includes：By Moringa, Folium Ginkgo, Fructus Crataegi, Folium Nelumbinis, Semen Cassiae, Fructus Lycii, Poria
And boiled with decocting after Radix Ginseng mixing, decoct 0.5-1h every time, decoct 2-4 time, merging filtrate, be concentrated to give extractum.Remaining is former
Material is crushed to mix homogeneously after 100-300 mesh respectively, then mixes with above-mentioned extractum, plus appropriate amount of ethanol makes granule, is dried, granulate
Obtain final product.
Embodiment 2
The compositionss of a kind of regulation blood fat, blood pressure and blood glucose that the present embodiment provides, in parts by weight, said composition
Raw material include：2200 parts of probiotic bacteria ferment, 30 parts of L-arabinose, 2 parts of Moringa, 10 parts of samara oil, 5 parts of Folium Ginkgo, krill
10 parts of oil, 2 parts of bathypelagic fish oil, 10 parts of DHA algal oil, 2 parts of Semen Lini oil, 10 parts of Camellia oil, 2 parts of Fructus Crataegi, 10 parts of Folium Nelumbinis, Semen Cassiae
2 parts of son, 10 parts of fruit-vegetable fibre, 2 parts of Five-grain fiber, 1 part of Rhizoma amorphophalli, 5 parts of Rhizoma Steudnerae Henryanae, 1 part of Fructus Lycii, 5 parts of Poria, 1 part of Radix Ginseng and Herba Marsileae Quadrifoliae
10 parts of fruit juice.
This combination is prepared into capsule, it includes：Said composition is made granule, it includes：By Moringa, Semen Ginkgo
Boiled with decocting after leaf, Fructus Crataegi, Folium Nelumbinis, Semen Cassiae, Fructus Lycii, Poria and Radix Ginseng mixing, decoct 0.5-1h every time, decoct 2-4 time, close
And filtrate, it is concentrated to give extractum.Remaining raw material is crushed to mix homogeneously after 100-300 mesh respectively, then mixes with above-mentioned extractum,
Plus appropriate amount of ethanol makes granule, it is dried, load capsule and obtain final product.
Embodiment 3
The compositionss of a kind of regulation blood fat, blood pressure and blood glucose that the present embodiment provides, in parts by weight, said composition
Raw material include：1800 parts of probiotic bacteria ferment, 5 parts of L-arabinose, 10 parts of Moringa, 2 parts of samara oil, 15 parts of Folium Ginkgo, krill
3 parts of oil, 10 parts of bathypelagic fish oil, 2 parts of DHA algal oil, 10 parts of Semen Lini oil, 2 parts of Camellia oil, 10 parts of Fructus Crataegi, 2 parts of Folium Nelumbinis, Semen Cassiae
10 parts of son, 2 parts of fruit-vegetable fibre, 10 parts of Five-grain fiber, 5 parts of Rhizoma amorphophalli, 1 part of Rhizoma Steudnerae Henryanae, 5 parts of Fructus Lycii, 1 part of Poria, 5 parts of Radix Ginseng and Herba Marsileae Quadrifoliae
2 parts of fruit juice.
This combination is prepared into powder, it includes：By Moringa, Folium Ginkgo, Fructus Crataegi, Folium Nelumbinis, Semen Cassiae, Fructus Lycii, Poria and
Boiled with decocting after Radix Ginseng mixing, decoct 0.5-1h every time, decoct 2-4 time, merging filtrate, be concentrated to give extractum, above-mentioned leaching is dried
Cream gets dry extract powder.Remaining raw material is crushed to mix homogeneously after 100-300 mesh respectively, then mixs homogeneously with above-mentioned dried cream powder and be
?.
Embodiment 4
The compositionss of a kind of regulation blood fat, blood pressure and blood glucose that the present embodiment provides, in parts by weight, said composition
Raw material include：2000 parts of probiotic bacteria ferment, 10 parts of L-arabinose, 3 parts of Moringa, 5 parts of samara oil, 12 parts of Folium Ginkgo, krill
5 parts of oil, 3 parts of bathypelagic fish oil, 5 parts of DHA algal oil, 3 parts of Semen Lini oil, 5 parts of Camellia oil, 3 parts of Fructus Crataegi, 2 parts of Folium Nelumbinis, Semen Cassiae 8
Part, 3 parts of fruit-vegetable fibre, 5 parts of Five-grain fiber, 3 parts of Rhizoma amorphophalli, 2 parts of Rhizoma Steudnerae Henryanae, 2 parts of Fructus Lycii, 1 part of Poria, 2 parts of Radix Ginseng and Sucus Mali pumilae 5
Part.
Said composition is made granule, it includes：By Moringa, Folium Ginkgo, Fructus Crataegi, Folium Nelumbinis, Semen Cassiae, Fructus Lycii, Poria
And boiled with decocting after Radix Ginseng mixing, decoct 0.5-1h every time, decoct 2-4 time, merging filtrate, be concentrated to give extractum.Remaining is former
Material is crushed to mix homogeneously after 100-300 mesh respectively, then mixes with above-mentioned extractum, plus appropriate amount of ethanol makes granule, is dried, granulate
Obtain final product.
Embodiment 5
The compositionss of a kind of regulation blood fat, blood pressure and blood glucose that the present embodiment provides, in parts by weight, said composition
Raw material include：2000 parts of probiotic bacteria ferment, 20 parts of L-arabinose, 5 parts of Moringa, 3 parts of samara oil, 10 parts of Folium Ginkgo, krill
7 parts of oil, 5 parts of bathypelagic fish oil, 3 parts of DHA algal oil, 5 parts of Semen Lini oil, 3 parts of Camellia oil, 5 parts of Fructus Crataegi, 3 parts of Folium Nelumbinis, Semen Cassiae 5
Part, 5 parts of fruit-vegetable fibre, 3 parts of Five-grain fiber, 32 parts of Rhizoma amorphophalli, 3 parts of Rhizoma Steudnerae Henryanae, 1 part of Fructus Lycii, 2 parts of Poria, 1 part of Radix Ginseng and Sucus Mali pumilae
3 parts.
Said composition is made granule, it includes：By Moringa, Folium Ginkgo, Fructus Crataegi, Folium Nelumbinis, Semen Cassiae, Fructus Lycii, Poria
And boiled with decocting after Radix Ginseng mixing, decoct 0.5-1h every time, decoct 2-4 time, merging filtrate, be concentrated to give extractum.Remaining is former
Material is crushed to mix homogeneously after 100-300 mesh respectively, then mixes with above-mentioned extractum, plus appropriate amount of ethanol makes granule, is dried, granulate
Obtain final product.
Embodiment 6
The compositionss of a kind of regulation blood fat, blood pressure and blood glucose that the present embodiment provides, in parts by weight, said composition
Raw material include：2000 parts of probiotic bacteria ferment, 15 parts of L-arabinose, 4 parts of Moringa, 4 parts of samara oil, 11 parts of Folium Ginkgo, krill
6 parts of oil, 4 parts of bathypelagic fish oil, 4 parts of DHA algal oil, 4 parts of Semen Lini oil, 4 parts of Camellia oil, 4 parts of Fructus Crataegi, 2 parts of Folium Nelumbinis, Semen Cassiae 7
Part, 4 parts of fruit-vegetable fibre, 4 parts of Five-grain fiber, 3 parts of Rhizoma amorphophalli, 2 parts of Rhizoma Steudnerae Henryanae, 2 parts of Fructus Lycii, 1 part of Poria, 2 parts of Radix Ginseng, 4 parts of Sucus Mali pumilae,
1 part of sodium carboxymethyl cellulose, 2 parts of citric acid, 2 parts of malic acid, 2 parts of organic trivalent chromium and 2 parts of chromium picolinate.
Said composition is made granule, it includes：By Moringa, Folium Ginkgo, Fructus Crataegi, Folium Nelumbinis, Semen Cassiae, Fructus Lycii, Poria
And boiled with decocting after Radix Ginseng mixing, decoct 0.5-1h every time, decoct 2-4 time, merging filtrate, be concentrated to give extractum.Remaining is former
Material is crushed to mix homogeneously after 100-300 mesh respectively, then mixes with above-mentioned extractum, plus appropriate amount of ethanol makes granule, is dried, granulate
Obtain final product.
Embodiment 7
The compositionss of a kind of regulation blood fat, blood pressure and blood glucose that the present embodiment provides, in parts by weight, said composition
Raw material include：2000 parts of probiotic bacteria ferment, 15 parts of L-arabinose, 4 parts of Moringa, 4 parts of samara oil, 11 parts of Folium Ginkgo, krill
6 parts of oil, 4 parts of bathypelagic fish oil, 4 parts of DHA algal oil, 4 parts of Semen Lini oil, 4 parts of Camellia oil, 4 parts of Fructus Crataegi, 2 parts of Folium Nelumbinis, Semen Cassiae 7
Part, 4 parts of fruit-vegetable fibre, 4 parts of Five-grain fiber, 3 parts of Rhizoma amorphophalli, 2 parts of Rhizoma Steudnerae Henryanae, 2 parts of Fructus Lycii, 1 part of Poria, 2 parts of Radix Ginseng, 4 parts of Sucus Mali pumilae,
2 parts of sodium carboxymethyl cellulose, 2 parts of citric acid, 2 parts of malic acid, 2 parts of organic trivalent chromium, 2 parts of chromium picolinate, 20 parts of starch, hard
5 parts of fatty acid magnesium and 3 parts of oligosaccharide.
Said composition is made tablet, it includes：By Moringa, Folium Ginkgo, Fructus Crataegi, Folium Nelumbinis, Semen Cassiae, Fructus Lycii, Poria and
Boiled with decocting after Radix Ginseng mixing, decoct 0.5-1h every time, decoct 2-4 time, merging filtrate, be concentrated to give extractum.By remaining raw material
It is crushed to mix homogeneously after 100-300 mesh respectively, then mixes with above-mentioned extractum, plus appropriate amount of ethanol makes granule, tabletted, do
Dry obtain final product.
Test example 1
Choose hypertension to occur together hyperlipemic patients 140,140 are all high patient of both cholesterol and triglyceride,
Meet the diagnostic criteria of hyperlipidemia：Diagnostic Value of Fasting Serum T-CHOL (TC) ＞ 6.5mmol/L, triglyceride (TG) is more than
1.24mmol/L.And meet Evaluation of Diagnostic Criteria of Hypertension：Diastolic pressure >=90mmHg.Clinical symptoms show as dizziness, headache, shortness of breath,
Tachypnea etc..Age 30-60 year, 48.53 years old mean age, wherein male 70, women 70, patient is divided into matched group and reality
Test group, every group is respectively 70, and matched group and experimental group are men and women patient half and half, and two groups of mean age is suitable.
Therapeutic Method：First course for the treatment of is 20d, and experimental group and matched group all give conventional therapy, and experimental group gives simultaneously
The granule that the embodiment of the present invention 1 provides, daily 1-2 time, each 10-30g.Second course for the treatment of is 10d, experimental group and matched group
All do not give conventional therapy, simultaneously experimental group give the embodiment of the present invention 1 offer granule, daily 1-2 time, each 10-
30g.
Observation index：Effective：Clinical symptom disappearance, diastole drops >=10mmHg, TC declines ＞ 20%, and TG declines ＞
40%；Effectively：Clinical symptoms are obviously improved, diastole drops >=10mmHg, and TC declines ＞ 10～20%, TG decline ＞ 20～
40%；Invalid：Clinical symptoms are not improved, and TC declines ＜ 10%, and TG is dropped by less than 20%.
Result of the test：
1. Comparison of therapeutic：The total effective rate of experimental group and matched group is respectively 98.6% and 88.4%, always the having of experimental group
Efficiency is apparently higher than matched group (p ＜ 0.05).And experimental group obvious effective rate equally apparently higher than matched group (p ＜ 0.05).
Table 1 experimental group and the Comparison of therapeutic of matched group
| Group | Number of cases | Effective | Effectively | Invalid | Obvious effective rate | Total effective rate |
| Matched group | 70 | 39 | 23 | 8 | 55.7% | 88.6% |
| Experimental group | 70 | 62 | 7 | 1 | 88.6% | 98.6%* |
*：P ＜ 0.05
2. blood lipids index contrast：TG and TC value contrast equal no difference of science of statistics (p ＞ before experimental group and matched group test
0.05), after test, TG and TC value all substantially reduces (p ＜ 0.05), and in group, contrast has significant difference (p ＜ and between group
0.05).Experimental group diastolic pressure drop-out value is significantly greater than matched group simultaneously.
The blood lipids index change table of table 2 experimental group and matched group
*：P ＜ 0.05
Test example 2
Select the state of an illness after diet control or oral antidiabetic drug treatment relatively stable it is not necessary to change types of drugs and dosage,
Only take the adult Patients with NIDDM 100 of maintenance dose, selection standard：Fasting glucose >=7.8mmol/L (140mg/dL)
Or 2h-plasma glucose >=11.1mmol/L (200mg/dL).During test, experimenter disables treatment diabetes medicament and other have
Close health food, take the embodiment of the present invention 1 offer granule, daily 2 times, each 20g, continuously take 2 months.
Test result show, after patients with NIDDM takes the compositionss of the present invention, thirsty polydipsia, polyorexia,
The main clinic symptoms such as fatigue and weakness, polyuria all have clear improvement, and no side effects during taking.
To sum up, the compositionss that the present invention provides have obvious blood fat reducing, blood pressure lowering and hypoglycemic effect, in compositionss
There is several functions composition, including active bacteria, unsaturated fatty acid, dietary fiber etc., can adjust the blood fat of body, blood pressure and
Blood sugar level, makes body be in health status, has good health care and treatment for hyperlipidemia, hypertension and hyperglycemic patients
Effect.
Embodiments described above is a part of embodiment of the present invention, rather than whole embodiments.The reality of the present invention
The detailed description applying example is not intended to limit the scope of claimed invention, but is merely representative of the selected enforcement of the present invention
Example.Based on the embodiment in the present invention, those of ordinary skill in the art are obtained under the premise of not making creative work
Every other embodiment, broadly falls into the scope of protection of the invention.
Claims (10)
1. a kind of adjust blood fat, blood pressure and blood glucose compositionss it is characterised in that in parts by weight, described compositionss
Raw material includes：Probiotic bacteria ferment 1800-2200 part, L-arabinose 5-30 part, Moringa 2-10 part, samara oil 2-10 part, Semen Ginkgo
Leaf 5-15 part, krill oil 3-10 part, bathypelagic fish oil 2-10 part, DHA algal oil 2-10 part, Semen Lini oil 2-10 part, Camellia oil 2-
10 parts, Fructus Crataegi 2-10 part, Folium Nelumbinis 2-10 part, Semen Cassiae 3-10 part, fruit-vegetable fibre 2-10 part, Five-grain fiber 2-10 part, Rhizoma amorphophalli 1-5
Part, Rhizoma Steudnerae Henryanae 1-5 part, Fructus Lycii 1-5 part, Poria 1-5 part, Radix Ginseng 1-5 part and Sucus Mali pumilae 2-10 part.
2. the compositionss adjusting blood fat, blood pressure and blood glucose according to claim 1 are it is characterised in that according to parts by weight
Meter, described probiotic bacteria ferment is 2000 parts, and described L-arabinose is 10-20 part, and described Moringa is 3-5 part, described samara oil
For 3-5 part, described Folium Ginkgo is 10-12 part, and described krill oil is 5-7 part, and described bathypelagic fish oil is 3-5 part, described DHA algal oil
For 3-5 part, described Semen Lini oil is 3-5 part, and described Camellia oil is 3-5 part, and described Fructus Crataegi is 3-5 part, and described Folium Nelumbinis are 2-3
Part, described Semen Cassiae is 5-8 part, and described fruit-vegetable fibre is 3-5 part, and described Five-grain fiber is 3-5 part, and described Rhizoma amorphophalli is 2-3 part,
Described Rhizoma Steudnerae Henryanae is 2-3 part, and described Fructus Lycii is 1-2 part, and described Poria is 1-2 part, and described Radix Ginseng is 1-2 part, and described Sucus Mali pumilae is
3-5 part.
3. the compositionss adjusting blood fat, blood pressure and blood glucose according to claim 1 are it is characterised in that according to parts by weight
Meter, described raw material also includes：Sodium carboxymethyl cellulose, citric acid, malic acid, organic trivalent chromium and chromium picolinate.
4. the compositionss adjusting blood fat, blood pressure and blood glucose according to claim 1 are it is characterised in that described probiotic bacteria ferment
Element mainly by probiotic bacteria on probiotic bacteria culture medium cultivation and fermentation be obtained, in parts by weight, described probiotic bacteria includes：Youth
Bacillus bifiduss 20-100 part, bacillus acidophilus' 20-100 part, lactobacillus thermophiluss 20-100 part, bifidobacterium breve 20-100 part, length
Bacillus bifiduss 20-100 part and Lactobacillus plantarum 20-100 part.
5. the compositionss adjusting blood fat, blood pressure and blood glucose according to claim 4 are it is characterised in that according to parts by weight
Meter, the main component of described probiotic bacteria culture medium is mushroom polysaccharide, algal polysaccharides, Plant Powder, pollen, water fruits and vegetables and five
Paddy.
6. the compositionss adjusting blood fat, blood pressure and blood glucose according to claim 1 are it is characterised in that described fruit-vegetable fibre
Including apple fiber, banana fiber, pina fibre, Fructus Jujubae fiber, Herba Apii graveolentis fiber and carrot fiber.
7. the compositionss adjusting blood fat, blood pressure and blood glucose according to claim 1 are it is characterised in that described Five-grain fiber
Including Herba avenae fatuae fiber, soybean fiber, Semen Coicis fiber, Semen sojae atricolor fiber and buckwheat fibers.
8. the compositionss adjusting blood fat, blood pressure and blood glucose according to claim 1 are it is characterised in that described raw material also wraps
Include pharmaceutically acceptable adjuvant.
9. the compositionss according to claim 1-8 any one are in preparation blood fat reducing, blood pressure lowering or hypoglycemic drug
Application.
10. the compositionss according to claim 1-8 any one are in preparation blood fat reducing, blood pressure lowering or blood sugar reducing food
Application.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610818255.8A CN106387900A (en) | 2016-09-09 | 2016-09-09 | Composition for regulating blood lipid, blood pressure and blood sugar, as well as application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610818255.8A CN106387900A (en) | 2016-09-09 | 2016-09-09 | Composition for regulating blood lipid, blood pressure and blood sugar, as well as application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106387900A true CN106387900A (en) | 2017-02-15 |
Family
ID=57999049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610818255.8A Pending CN106387900A (en) | 2016-09-09 | 2016-09-09 | Composition for regulating blood lipid, blood pressure and blood sugar, as well as application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106387900A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109567207A (en) * | 2018-12-28 | 2019-04-05 | 安徽济生元药业有限公司 | It is a kind of can reducing blood lipid blood glucose fish oil krill oil capsule and preparation method thereof |
| CN113016971A (en) * | 2019-12-09 | 2021-06-25 | 南京宿根花卉植物园有限公司 | Solid beverage for reducing blood pressure |
| CN113115932A (en) * | 2019-12-30 | 2021-07-16 | 黑龙江北货郎森林食品有限公司 | Weight-losing capsule containing black fungus dietary fiber and preparation method thereof |
| CN113229429A (en) * | 2021-05-22 | 2021-08-10 | 安徽龙纪元生物科技有限公司 | Hypolipidemic composition beverage and preparation method thereof |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101584833A (en) * | 2008-05-19 | 2009-11-25 | 李翔 | Pu-er tea ferment soft capsule and production method thereof |
| CN101999731A (en) * | 2010-12-14 | 2011-04-06 | 陈佩诗 | Original fruit enzyme oral liquid and preparation method thereof |
| CN102763800A (en) * | 2012-08-16 | 2012-11-07 | 梅晓芳 | Health care fruit and vegetable powder composed of antioxidative and cholesterol removal foods and drugs capable of benefiting vital energy, invigorating blood circulation and eliminating stasis |
| CN102860451A (en) * | 2012-09-10 | 2013-01-09 | 厦门金日制药有限公司 | Composite with function of assisting in decreasing blood glucoses and products thereof |
| CN102987206A (en) * | 2012-12-27 | 2013-03-27 | 上海普维健康食品有限公司 | Composition capable of reducing blood glucose |
| CN103284038A (en) * | 2012-12-27 | 2013-09-11 | 福建永生活力生物工程有限公司 | Hyperglycemic composition and preparation method thereof |
| CN103404921A (en) * | 2013-07-09 | 2013-11-27 | 天津市星河系科技有限公司 | Fruit/vegetable ferment composition and preparation method thereof |
| CN104814503A (en) * | 2015-05-21 | 2015-08-05 | 厦门益力康生物科技有限公司 | Fruit and vegetable enzyme solid beverage and preparation method thereof |
| CN104855979A (en) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-full nutritional formula food for patients with hyperlipidemia |
| CN105029603A (en) * | 2015-06-24 | 2015-11-11 | 陈琳仁 | Composite fresh flower, fruit, vegetable and herb enzyme, and preparation method and application thereof |
-
2016
- 2016-09-09 CN CN201610818255.8A patent/CN106387900A/en active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101584833A (en) * | 2008-05-19 | 2009-11-25 | 李翔 | Pu-er tea ferment soft capsule and production method thereof |
| CN101999731A (en) * | 2010-12-14 | 2011-04-06 | 陈佩诗 | Original fruit enzyme oral liquid and preparation method thereof |
| CN102763800A (en) * | 2012-08-16 | 2012-11-07 | 梅晓芳 | Health care fruit and vegetable powder composed of antioxidative and cholesterol removal foods and drugs capable of benefiting vital energy, invigorating blood circulation and eliminating stasis |
| CN102860451A (en) * | 2012-09-10 | 2013-01-09 | 厦门金日制药有限公司 | Composite with function of assisting in decreasing blood glucoses and products thereof |
| CN102987206A (en) * | 2012-12-27 | 2013-03-27 | 上海普维健康食品有限公司 | Composition capable of reducing blood glucose |
| CN103284038A (en) * | 2012-12-27 | 2013-09-11 | 福建永生活力生物工程有限公司 | Hyperglycemic composition and preparation method thereof |
| CN103404921A (en) * | 2013-07-09 | 2013-11-27 | 天津市星河系科技有限公司 | Fruit/vegetable ferment composition and preparation method thereof |
| CN104855979A (en) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-full nutritional formula food for patients with hyperlipidemia |
| CN104814503A (en) * | 2015-05-21 | 2015-08-05 | 厦门益力康生物科技有限公司 | Fruit and vegetable enzyme solid beverage and preparation method thereof |
| CN105029603A (en) * | 2015-06-24 | 2015-11-11 | 陈琳仁 | Composite fresh flower, fruit, vegetable and herb enzyme, and preparation method and application thereof |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109567207A (en) * | 2018-12-28 | 2019-04-05 | 安徽济生元药业有限公司 | It is a kind of can reducing blood lipid blood glucose fish oil krill oil capsule and preparation method thereof |
| CN113016971A (en) * | 2019-12-09 | 2021-06-25 | 南京宿根花卉植物园有限公司 | Solid beverage for reducing blood pressure |
| CN113115932A (en) * | 2019-12-30 | 2021-07-16 | 黑龙江北货郎森林食品有限公司 | Weight-losing capsule containing black fungus dietary fiber and preparation method thereof |
| CN113229429A (en) * | 2021-05-22 | 2021-08-10 | 安徽龙纪元生物科技有限公司 | Hypolipidemic composition beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102919836B (en) | Health-care product capable of reducing blood glucose, releasing pressure, reducing lipid, relaxing bowel, beautifying, losing weight and resisting fatigue and production process thereof | |
| CN103099089B (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
| CN101744170B (en) | Tartary buckwheat eight ingredient porridge suitable for patients with diabetes and preparing method thereof | |
| CN102907604B (en) | Health-care product having effects of reducing blood sugar and pressure, losing weight, relaxing bowels, maintaining beauty and resisting fatigue and production process thereof | |
| CN106605909A (en) | Composition capable of relaxing the bowels, expelling toxin and preventing constipation, as well as preparation method thereof | |
| EP3530277A1 (en) | Chinese medicine healthcare preparations for slimming and weight loss | |
| CN102511869B (en) | Thickened red jujube ginger pulp | |
| CN105249326A (en) | Fermented fruit and vegetable composition containing probiotics and traditional Chinese medicine extract and preparation method of fermented fruit and vegetable composition | |
| CN109123643A (en) | A kind of preparation method of cereal generation meal ball | |
| CN105942498A (en) | Functional nutritional food compounds with diabetes-treating effects and preparation methods thereof | |
| CN106387900A (en) | Composition for regulating blood lipid, blood pressure and blood sugar, as well as application thereof | |
| CN105232907A (en) | Beverage capable of invigorating kidney and strengthening Yang and making method thereof | |
| CN105124347A (en) | Moringa oleifera blood-glucose-reducing composition and preparation method thereof | |
| CN108524673A (en) | A kind of Chinese medicine composition and its application | |
| CN105707876B (en) | It is a kind of that there is the dietary composition and its preparation method and application stablized and dissolve patch | |
| CN105943958A (en) | Inonotus obliquus composite solid particles for treating gout and preparing method thereof | |
| CN104543767A (en) | Blood glucose-reduction dieto-therapeutic noodle and preparation method thereof | |
| KR101227922B1 (en) | Papaya puree and the use of the same | |
| CN107616491A (en) | A kind of functional food for being used to prevent and treat diabetes | |
| CN107136513A (en) | Adjust the health food of colony balance, preparation method and applications in human body | |
| CN106138900A (en) | Auxiliary treats hyperglycemia and the compositions of diabetic complication and application thereof | |
| CN106234896A (en) | A kind of health promoting beverage treating nephropathy and preparation method thereof | |
| CN105106721A (en) | Health product with efficacy of reducing blood sugar | |
| CN100379346C (en) | Method for preparing sour milk contg. micron sugared ginseng, bee-glue etc. for tonifying-Yin and nourishing-stomach | |
| CN104673573A (en) | Wine with diabetes prevention and treatment function and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170215 |
|
| RJ01 | Rejection of invention patent application after publication |